Market Overview

Small Animal Imaging (In-vivo) Market Projected to Reach $2.2 Billion, 2018 Report


Small Animal Imaging (In-vivo) Market Projected to Reach $2.2 Billion, 2018 Report

PR Newswire

DUBLIN, Aug. 31, 2018 /PRNewswire/ --

Research and Markets Logo. (PRNewsFoto/Research and Markets) (PRNewsfoto/Research and Markets)

The "Small Animal Imaging (In-vivo) Market Size, Share & Trends Analysis Report By Technology (Optical Imaging, Micro-Magnetic Resonance Imaging, Nuclear Imaging), By Application, And Segment Forecasts, 2012 - 2022" report has been added to's offering.

The global small animal imaging (In-Vivo) market size is expected to reach 2.7 billion by 2022, progressing at a CAGR of 9.0% during the forecast period.

Rising number of medical conditions requiring precise research for development of treatment options is anticipated to stoke the demand for small animal imaging over the forecast period.

Importance of these devices in applications such as defining mechanism of action, drug receptor targeting, and epigenetic research studies are projected to provide substantial growth for the market. Some of the major drivers of small animal imaging (in-vivo) market are technical innovations such as high-resolution MRI with other modalities, growing number of research and pharmaceutical organizations, increasing investments of CROs in pre-clinical studies, and rising adoption of multi-functional pre-clinical imaging.

Further key findings from the report suggest:

  • Optical imaging was the largest segment in 2014 owing to rapid and easy operations and relatively cost-effective in comparison to other devices
  • Micro-MRI technology is anticipated to be the fastest growing segment over the forecast period due varied applications during anatomical and functional analysis in developing mouse embryos and neonates
  • In 2014, bio-distribution and monitoring the treatment response dominated the market in terms of revenue
  • The cancer cell detection segment is expected to show substantial growth due to the increasing prevalence of cancer and rising government initiatives for cancer diagnostics research
  • North America was the largest region in terms of revenue in 2016. Vast pre-clinical research, increasing demand for rapid and advanced methods, established healthcare infrastructure, and favorable platform for R&D pertaining to technological advancements are the key factors driving the regional market
  • Europe was the second largest region in 2014, due to a large number of clinical research and pharmaceutical organizations and diagnostic device manufacturers
  • Asia Pacific is projected to be the fastest growing region over the forecast period owing to increasing clinical research activities, rising base of target population, and emerging economies
  • Some of the key players are Promega Corporation, Inc.; Miltenyi Biotec GmbH; Life Technologies Corporation; FujiFilm Holding Corporation; Siemens AG; Thermo Fisher Scientific; Bruker Corporation; PerkinElmer Inc.; and Aspect Imaging Ltd.

Key Topics Covered:

Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources

Chapter 2. Executive Summary
2.1. Small Animal Testing (In-Vivo) market - Industry Summary and Key Buying Criteria, 2012 - 2022

Chapter 3. Small Animal Testing (In-Vivo) Industry Outlook
3.1. Small Animal Testing (In-Vivo) market segmentation
3.2. Small Animal Testing (In-Vivo) market size and growth prospects, 2012-2022
3.3. Small Animal Testing (In-Vivo) market dynamics
3.4. Key opportunities prioritized
3.5. Industry analysis - Porter's
3.6. Small Animal Testing (In-Vivo) market PESTEL analysis, 2014

Chapter 4. Small Animal Imaging (In-Vivo) Technology Outlook
4.1. Small Animal Imaging (In-Vivo) Market Share By Technology, 2014 & 2022
4.2. Micro-magnetic resonance imaging
4.3. Optical imaging
4.4. Nuclear imaging
4.5. Other imaging modalities

Chapter 5. Small Animal Imaging (In-Vivo) Application Outlook
5.1. Small Animal Imaging (In-Vivo) Market Share By Application, 2014 & 2022
5.2. Monitoring treatment response
5.3. Bio-distribution, determining drug/target engagement
5.4. Cancer cell detection
5.5. Biomarkers
5.6. Longitudinal studies
5.7. Epigenetics

Chapter 6. Small Animal Imaging (In-Vivo) Regional Outlook

Chapter 7. Competitive Landscape

  • Thermo Fisher Scientific
  • Siemens AG
  • Life Technologies Corporation
  • Bruker Corporation
  • PerkinElmer, Inc
  • Aspect Imaging Ltd.
  • Promega Corporation

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content with multimedia:

SOURCE Research and Markets

View Comments and Join the Discussion!